Sort
261,768 grants matching “gene therapy”
Cellular Interactions with Thrombospondin
$1,414,291David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities
$1,414,272Lois B. Travis · University Of Rochester · R01 · FY2013 · CA
Epigenetic mechanisms regulating the Igf2/H19 and Kcnq1 locus
$1,414,139Karl Eric Pfeifer · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
$1,414,061Xianyu S Hou · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Therapeutic Vaccination for HIV Using VEE Vectors
$1,413,970University Of North Carolina Chapel Hill · P01 · FY2004 · AI
NHGRI/DIR Technology Transfer Program
$1,413,857Claire Driscoll · National Human Genome Research Institute · ZIK · FY2020 · HG
Remodeling and recovery in the neurovascular unit
$1,413,847Eng H. Lo · Massachusetts General Hospital · P01 · FY2015 · NS
Vascular remodeling in patients with rare genetic disorders
$1,413,751Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
MRI Studies of Brain Function and Metabolism
$1,413,684Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2013 · MH
Disease mechanism and therapies for retinal degeneration
$1,413,623Tiansen Li · National Eye Institute · ZIA · FY2013 · EY
Genome-Wide Association Studies of Adiposity in Samoans
$1,413,321Stephen T. McGarvey · Brown University · R01 · FY2009 · HL
Synthetic Cell State Engineering for Primary Human Cellular Therapies
$1,413,277Theodore Lee Roth · Stanford University · DP2 · FY2025 · CA
Improving Mitral Compensation In Ischemic Regurgitation
$1,413,244Robert A Levine · Massachusetts General Hospital · R01 · FY2018 · HL
The LUCINDA Trial
$1,413,113Tracy A. Butler · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AG
Muscular Dystrophy Cooperative Research Center
$1,412,829Richard T Moxley · University Of Rochester · U54 · FY2012 · NS
Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders
$1,412,771Allen Bernard Reitz · Fox Chase Chemical Diversity Center, Inc · U01 · FY2021 · AG
Pathogenesis of Novel Forms of Osteogenesis Imperfecta
$1,412,624Brendan Hl Lee · Baylor College Of Medicine · P01 · FY2019 · HD
Pathogenesis of Novel Forms of Osteogenesis Imperfecta
$1,412,624Brendan Hl Lee · Baylor College Of Medicine · P01 · FY2017 · HD
Pathogenesis of Novel Forms of Osteogenesis Imperfecta
$1,412,624Brendan Hl Lee · Baylor College Of Medicine · P01 · FY2018 · HD
Pathogenesis of Novel Forms of Osteogenesis Imperfecta
$1,412,624Brendan Hl Lee · Baylor College Of Medicine · P01 · FY2020 · HD
Mechanisms of dopamine neuron degeneration
$1,412,585Robert E Burke · Columbia University Health Sciences · P50 · FY2006 · NS
Gene Therapy for Brain Tumors
$1,412,570Fred H Hochberg · Massachusetts General Hospital · P01 · FY2009 · CA
Mechanisms of dopamine neuron degeneration
$1,412,467Robert E Burke · Columbia University Health Sciences · P50 · FY2007 · NS
Next generation T cell therapies for mutant KRAS solid tumors
$1,412,213Beatriz M. Carreno · University Of Pennsylvania · UG3 · FY2024 · CA
Mechanisms of dopamine neuron degeneration
$1,412,203Robert E Burke · Columbia University Health Sciences · P50 · FY2008 · NS